Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.49 |
| ▸ | HDAC1 | Q13547 | 13/20 | 0.36 |
| ▸ | HDAC6 | Q9UBN7 | 10/20 | 0.36 |
| ▸ | EHMT1 | Q9H9B1 | 6/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | HDAC2 | Q92769 | 7/20 | 0.34 |
| ▸ | HDAC3 | O15379 | 5/20 | 0.34 |
| ▸ | HDAC4 | P56524 | 5/20 | 0.34 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.34 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.34 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.34 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.34 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.34 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5461883 | 0.87 | IDO1 (0.42) | IDO1HDAC1MAPTHDAC3 | |
| SCHEMBL5455315 | 0.82 | CA12 (0.46) | IDO1HDAC1HDAC6CYP3A4CYP2C9 | |
| SCHEMBL5452697 | 0.78 | IDO1 (0.45) | IDO1KDM4EMAPT | |
| SCHEMBL14428356 | 0.78 | IDO1 (0.60) | IDO1BRD4 | |
| SCHEMBL14428363 | 0.77 | IDO1 (0.47) | IDO1HDAC1KDM4EMAPTHDAC2 | |
| SCHEMBL14428353 | 0.76 | KCNH3 (0.47) | IDO1KDM4E | |
| SCHEMBL14428355 | 0.76 | NPY1R (0.44) | IDO1 | |
| SCHEMBL5457576 | 0.76 | IDO1 (0.47) | IDO1HDAC1KDM4ENPC1MAPT | |
| SCHEMBL5456625 | 0.75 | IDO1 (0.48) | IDO1HDAC1HDAC6KCNH2HDAC8 | |
| SCHEMBL25245106 | 0.75 | IDO1 (0.48) | IDO1KDM4ENPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070191372-A1 | Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy | AUCKLAND UNISERVICES LIMITED (NZ) | 2007-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070191372-A1 | Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy | HIF1AN, HIF1A, HYOU1 | IDO1 924/4885HDAC1 1200/4885HDAC6 2421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.